James J. Schutz, Chief Executive Officer at Sonoma Pharmaceuticals, Inc. (SNOA), bought 345 shares at $4.95 ($2K) on 2017-11-30, disclosed to the SEC on 2017-12-04.
Open-market purchase of $2k SNOA by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| SNOA | BUY | 2017-11-27 | $1K | — | Filing → |
| SNOA | BUY | 2017-08-10 | $5K | — | Filing → |
| SNOA | BUY | 2017-03-07 | $5K | — | Filing → |